AMA Endeavors to Increase Transparency of Rx Pricing

Share this content:
AMA Endeavors to Increase Transparency of Rx Pricing
AMA Endeavors to Increase Transparency of Rx Pricing

THURSDAY, June 15, 2017 (HealthDay News) -- The American Medical Association (AMA) is calling for more transparency in drug pricing amid rising costs that are putting some lifesaving medications out of reach for patients and communities.

During its annual meeting, the physicians' group adopted new policies on drug pricing to protect patients. One policy calls on pharmaceutical companies to list the suggested retail prices of drugs in direct-to-consumer advertising. The AMA will urge federal regulators to include that requirement. The association pointed out that one study found a 34.2 percent increase in prices for prescription drugs advertised directly to consumers. For other medications, the increase was 5.1 percent.

Another policy is meant to tackle the sudden increase in the cost of naloxone. Community groups, schools, first responders, and local governments rely on naloxone to save lives, but are finding it increasingly expensive. The AMA plans to raise awareness about the recent actions of the three makers of naloxone. The companies sought the help of physicians, community groups, and elected officials to raise awareness and insurance coverage of naloxone and then suddenly and significantly boosted the cost of the drug after public policy changes increased access to naloxone, according to the association.

A third new policy calls on drug companies to give public notice before increasing the price of certain drugs by more than 10 percent during a 12-month period. This would provide information about the most serious cases of price gouging, particularly for older drugs, according to the AMA.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Zika Does Not Appear to Last in Semen As Long As Thought

Zika Does Not Appear to Last in Semen ...

More research is needed to better inform public health recommendations

Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke Risk

Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke ...

I-131 therapy group showed no significantly higher risk of ischemic or hemorrhagic stroke

Higher Odds of Infection With Reduced Kidney Function

Higher Odds of Infection With Reduced Kidney Function

Study finds excess community-acquired infections incidence in individuals with mild to severe CKD

is free, fast, and customized just for you!

Already a member?

Sign In Now »